🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Central Awareness in Women With Endometriosis

Recruitingn/aAges 18 Years - 50 YearsFemaleIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06773065 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Gathering some information obtained during the gynaecological examination and transvaginal ultrasound check-up to be able to assess the prevalence of Central Sensitisation Syndrome (CSS) in women with endometriosis and also to be able to assess related risk factors. CSS has been defined as an algic syndrome due to a hyperactivation of the sensitivity circuit at a central level; the diagnosis is based on the result obtained from a questionnaire, the Central Sensitisation Inventory (CSI), which evaluates the presence and intensity of 25 clinical symptoms. For this reason, a questionnaire is proposed to be completed at the time of the check-up visit.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women with a clinical, ultrasound and/or surgical diagnosis of endometriosis * Aged between 18 and 50 years * Patients starting or already taking hormone therapy * Patients coming for a first visit or outpatient follow-up visit * Signature of informed consent to participate in the study Exclusion Criteria: * Post-menopausal women (spontaneous or iatrogenic) * Virgo patients * Patients with poor compliance with hormone therapy, who are not taking it properly or have discontinued therapy spontaneously * Positive history of any malignant neoplasm * Positive medical history of specific medical conditions that adversely affect the central nervous system, such as: brain or spinal cord damage, neurological diseases or peripheral nerve damage, multiple sclerosis
💊

What it tests

  • Not listed
📍

Where

1 site
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy